Cargando…
Rituximab May Have Positive Effect on Refractory Nephrotic Syndrome: A Meta-Analysis of Randomized Trials
PURPOSE: This study was aimed at demonstrating the role of rituximab (RTX) on the influence of nephrotic syndrome (NS) and on urinary protein which was not significant. METHODS: The clinical randomized controlled trials were performed by eight databases. Meanwhile, the confidence interval (CI) of ei...
Autores principales: | Lin, Jingjing, Sun, Jia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262522/ https://www.ncbi.nlm.nih.gov/pubmed/35813445 http://dx.doi.org/10.1155/2022/3008597 |
Ejemplares similares
-
Retracted: Rituximab May Have Positive Effect on Refractory Nephrotic Syndrome: A Meta-Analysis of Randomized Trials
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: A meta-analysis
por: Zhao, Zhihong, et al.
Publicado: (2015) -
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
por: Xu, Jing, et al.
Publicado: (2021) -
Rituximab shows no effect on remission in patients with refractory nephrotic syndrome: A MOOSE-compliant meta-analysis
por: Yin, Supei, et al.
Publicado: (2016) -
Rituximab for nephrotic syndrome in children
por: Iijima, Kazumoto, et al.
Publicado: (2016)